Alfons A den Broeder

21PUBLICATIONS
81CO-AUTHORS
Medical infection agents (incl. prions)Toxicology (incl. clinical toxicology)Medical molecular engineering of nucleic acids and proteinsHaematological tumoursCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Feb 15, 2026
Measurement properties of the Polymyalgia Rheumatica Activity Score (PMR-AS): reliability, measurement error and discriminative validity.

Noortje E S E P Kooijman, David F Ten Cate, Pauline M E T Bovens

|Jan 23, 2026
Oral glucocorticoid premedication for preventing infusion-related reactions to rituximab in rheumatoid arthritis.

Pmet Bovens, L van Esveld, Mhm Wientjes

|Oct 23, 2025
Cohort Study on Drug Survival and Tolerability of Adalimumab Biosimilar Transitioning: Pharmaceutical Properties Do Matter.

Amy C D Peeters, Maike H M Wientjes, Wieland D Müskens

|Aug 25, 2025
Long-Term Routine Laboratory Toxicity Monitoring of Immunomodulatory Drugs in Rheumatoid Arthritis : A Retrospective Cohort Study.

Evy Ulijn, Nathan den Broeder, Karen Bevers

|Aug 13, 2025
Ischaemic cardiovascular risk with allopurinol and protective effect of colchicine in gout: a Dutch nationwide pharmaco-epidemiological study.

Iris Rose Peeters, Maike H M Wientjes, Isla S Mackenzie

|Aug 12, 2025
Continuation Versus Temporary Interruption of Immunomodulatory Agents During Infections in Patients With Inflammatory Rheumatic Diseases: A Randomized Controlled Trial.

Merel A A Opdam, Nathan den Broeder, Reinout van Crevel

Pageof 4

Frequent Collaborators

5 joint publications

Cornelia H M van den Ende

4 joint publications

Mat van Wissen

4 joint publications

Nathan den Broeder

4 joint publications

Tpm Vliet Vlieland